TRIB2 and liver cancer: The Wnt/β-catenin/TCF4 pathway promotes TRIB2 expression in liver cancer cells [38], and in this case TRIB2 also produces a negative feedback, via TRIB2-mediated ubiquitination and degradation of TCF4 and β-catenin through the E3 ligase binding region [12].